MENU
RARE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ultragenyx Pharmaceutical (RARE) Earnings Date & Reports
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
RARE is expected to report earnings to fall 33.15% to -123 cents per share on July 30
Q2'26
Est.
$-1.23
Q1'26
Missed
by $0.38
Q4'25
Missed
by $0.14
Q3'25
Missed
by $0.58
Q2'25
Beat
by $0.13
The last earnings report on May 05 showed earnings per share of -184 cents, missing the estimate of -146 cents. With 1.48M shares outstanding, the current market capitalization sits at 2.50B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of therapeutics for rare diseases
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1371
Web
https://www.ultragenyx.com